Synapse - William Pao

EGFR mutations in lung adenocarcinomas: Clinical testing experience in 334 consecutive cases and relationship to EGFR gene copy number and immunohistochemical expression

Meeting Abstract

Li, A. R.; Chitale, D.; Riely, G. J.; Pao, W.; Ma, Y.; Zheng, T.; Miller, V. A.; Zakowski, M. F.; Rusch, V.; Kris, M. G.; more...
Journal of Molecular Diagnostics (2007)

Fulltext@MSK | Save

Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib

Meeting Abstract

Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
Journal of Thoracic Oncology (2007)

Fulltext@MSK | Save

Identifying strategies to enhance responses induced by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas

Meeting Abstract

Gong, Y.; Somwar, R.; Politi, K.; Balak, M.; Chmielecki, J.; Jiang, X.; Pao, W.
Molecular Cancer Therapeutics (2007)

Fulltext@MSK | Save

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

Meeting Abstract

Bean, J.; Brennan, C.; Shih, J. Y.; Riely, G.; Viale, A.; Wang, L.; Chitale, D.; Motoi, N.; Szoke, J.; Broderick, S.; more...
Molecular Cancer Therapeutics (2007)

Fulltext@MSK | Save

Characterizing the cancer genome in lung adenocarcinoma

Journal Article

Weir, B. A.; Woo, M. S.; Getz, G.; Perner, S.; Ding, L.; Beroukhim, R.; Lin, W. M.; Province, M. A.; Kraja, A.; Johnson, L. A.; more...
Nature (2007)

Fulltext@MSK | Save

Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus

Journal Article

Riely, G. J.; Kris, M. G.; Zhao, B.; Akhurst, T.; Milton, D. T.; Moore, E.; Tyson, L.; Pao, W.; Rizvi, N. A.; Schwartz, L. H.; more...
Clinical Cancer Research (2007)

Fulltext@MSK | Save